Author

Shuangli Guo

Institution: Sarah Cannon

Observed institution: Sarah Cannon

OpenAlex ID: A5067743284

Pertuzumab + trastuzumab for HER2-amplified/overexpressed metastatic colorectal cancer (mCRC): Interim data from MyPathway.

2017 · Herbert Hurwitz, Kanwal Pratap Singh Raghav, et al. · Journal of Clinical Oncology · 38

Targeted therapy for advanced solid tumors based on molecular profiles: Early results from MyPathway, an open-label, phase IIa umbrella basket study.

2016 · John D. Hainsworth, Funda Meric-Bernstam, et al. · Journal of Clinical Oncology · 7

Works count: 2

Citation count: 45

H-index: 2

I10-index: 1